A PHASE II RANDOMIZED STUDY OF NovoTTF THERAPY VERSUS SUPPORTIVE CARE IN NON-SMALL CELL LUNG CANCER PATIENTS WITH 1-5 BRAIN METASTASES FOLLOWING OPTIMAL STANDARD LOCAL TREATMENT

被引：0
|
作者：
Weinberg, Uri [1 ]
Kirson, Eilon [2 ]
Farber, Ori [2 ]
Palti, Yoram [1 ]
机构：
[1] Novocure GmbH, Luzern, Switzerland
[2] Novocure Ltd, Haifa, Israel
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
10.1093/neuonc/nou265.35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NT-37
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases
    Wang, Zhen
    Yang, Jin-Ji
    Tu, Hai-Yan
    Yan, Hong-Hong
    Wu, Yi-Long
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (02) : 267 - 273
  • [22] Multicenter phase II study of temozolomide therapy for brain metastases in patients with malignant melanoma, breast cancer, or non-small cell lung cancer: Final results
    Danova, M.
    Bajetta, E.
    Crino, L.
    Del Prete, S.
    Cascinu, S.
    Salvagni, S.
    Siena, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] Weekly gemcitabine as a radiosensitiser for the treatment of brain metastases in patients with non-small cell lung cancer:phase Ⅰ trial
    Huang YJWu YLXie SXYang JJHuang YS and Liao RQDepartment of Lung CancerCancer CenterGuangdong Provincial Peoples HospitalGuangzhou China
    ChineseMedicalJournal, 2007, 120 (06) : 458 - 462
  • [24] Weekly gemcitabine as a radiosensitiser for the treatment of brain metastases in patients with non-small cell lung cancer:phase Ⅰ trial
    (Huang YJ
    中华医学杂志(英文版), 2007, (06) : 458 - 462
  • [25] Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases: a phase II study of the EORTC Lung Cancer Group (08965)
    Dziadziuszko, R
    Ardizzoni, A
    Postmus, PE
    Smit, EF
    Price, A
    Debruyne, C
    Legrand, C
    Giaccone, G
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (09) : 1271 - 1276
  • [26] Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II study
    Stathopoulos, G. P.
    Trafalis, D.
    Dimitroulis, J.
    Athanasiou, A.
    Koutantos, J.
    Anagnostopoulos, A.
    ONCOLOGY LETTERS, 2010, 1 (02) : 335 - 338
  • [27] Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized
    Arrieta, Oscar
    Hernandez-Pedro, Norma
    Maldonado, Federico
    Ramos-Ramirez, Maritza
    Yamamoto-Ramos, Masao
    Lopez-Macias, Diego
    Lozano, Francisco
    Zatarain-Barron, Zyanya Lucia
    Turcott, Jenny G.
    Barrios-Bernal, Pedro
    Orozco-Morales, Mario
    Flores-Estrada, Diana
    Cardona, Andres F.
    Rolfo, Christian
    Cacho-Diaz, Bernardo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (03): : 592 - 607
  • [28] A phase II study of icotinib and whole-brain radiotherapy in Chinese patients with brain metastases from non-small cell lung cancer
    Fan, Yun
    Huang, Zhiyu
    Fang, Luo
    Miao, Lulu
    Gong, Lei
    Yu, Haifeng
    Yang, Haiyan
    Lei, Tao
    Mao, Weimin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (03) : 517 - 523
  • [29] A phase II study of icotinib and whole-brain radiotherapy in Chinese patients with brain metastases from non-small cell lung cancer
    Yun Fan
    Zhiyu Huang
    Luo Fang
    Lulu Miao
    Lei Gong
    Haifeng Yu
    Haiyan Yang
    Tao Lei
    Weimin Mao
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 517 - 523
  • [30] Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
    Kim, Young Saing
    Cho, Eun Kyung
    Woo, Hyun Sun
    Hong, Junshik
    Ahn, Hee Kyung
    Park, Inkeun
    Sym, Sun Jin
    Kyung, Sun Young
    Kang, Shin Myung
    Park, Jeong-Woong
    Jeong, Sung Hwan
    Park, Jinny
    Lee, Jae Hoon
    Shin, Dong Bok
    CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 80 - 87
12345